Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.89 USD | -5.99% | -9.84% | -41.47% |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 525M | Capitalization | 1.01B |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -29M | EV / Sales 2024 * | 2.05 x |
Net cash position 2024 * | 63.34M | Net cash position 2025 * | 76.49M | EV / Sales 2025 * | 1.78 x |
P/E ratio 2024 * |
-26.9
x | P/E ratio 2025 * |
-33.5
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on AtriCure, Inc.
1 day | -5.99% | ||
1 week | -9.84% | ||
Current month | -13.39% | ||
1 month | -21.11% | ||
3 months | -37.27% | ||
6 months | -43.51% | ||
Current year | -41.47% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 52 | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 19-12-03 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 16-11-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 509 M€ | -.--% | ||
0.03% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 20.89 | -5.99% | 961,862 |
24-05-02 | 22.22 | -10.26% | 2,753,271 |
24-05-01 | 24.76 | +2.65% | 1,360,918 |
24-04-30 | 24.12 | +3.21% | 965,631 |
24-04-29 | 23.37 | +0.86% | 708,069 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.47% | 1.01B | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- ATRC Stock